Indication
Endometrioid Tumor
4 clinical trials
3 products
2 drugs
Clinical trial
A Phase II Randomized Trial of Olaparib Versus Olaparib Plus Tremelimumab in Platinum-Sensitive Recurrent Ovarian CancerStatus: Active (not recruiting), Estimated PCD: 2021-07-31
Product
OlaparibProduct
TremelimumabClinical trial
A Pilot Study of the Safety and Immunogenicity of Folate Receptor Alpha Peptide-Loaded Dendritic Cell Vaccination in Patients With Advanced Stage Epithelial Ovarian CancerStatus: Active (not recruiting), Estimated PCD: 2021-07-27
Clinical trial
A Phase 2 Multi-center Open-label Trial of Nab-Sirolimus in Combination With Letrozole in Advanced or Recurrent Endometrioid Endometrial CancerStatus: Recruiting, Estimated PCD: 2025-03-01
Drug
nab-sirolimusClinical trial
Laparoscopic Cytoreduction After Neoadjuvant ChemotherapyStatus: Recruiting, Estimated PCD: 2028-12-31
Drug
AN0025